Finance
Finance
HomeEVGN • NASDAQ
Evogene Ltd
$1.05
After Hours:
$1.03
(1.90%)-0.020
Closed: Dec 24, 3:53:47 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$1.05
Day range
$1.02 - $1.06
Year range
$0.95 - $2.42
Market cap
9.11M USD
Avg Volume
49.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2025Y/Y change
Revenue
312.00K-82.63%
Operating expense
2.88M-64.76%
Net income
3.87M150.77%
Net profit margin
1.24K392.27%
Earnings per share
-0.4664.51%
EBITDA
-2.44M64.22%
Effective tax rate
-0.04%
Total assets
Total liabilities
(USD)Sep 2025Y/Y change
Cash and short-term investments
15.96M-20.02%
Total assets
26.09M-34.97%
Total liabilities
8.83M-68.31%
Total equity
17.25M
Shares outstanding
8.72M
Price to book
8.04
Return on assets
-22.70%
Return on capital
-39.13%
Net change in cash
(USD)Sep 2025Y/Y change
Net income
3.87M150.77%
Cash from operations
-3.33M32.37%
Cash from investing
10.91M441.12%
Cash from financing
-10.34M-318.34%
Net change in cash
-2.70M-247.46%
Free cash flow
-385.62K-131.18%
About
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Founded
1999
Employees
117
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu